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Clay~drug interactions have been widely studied during the last de-
cade. However, the reaction mechanisms responsible of these interactions 
only have been elucidated in sorne cases (1,2). most of them when catio 
níc drugs are ínvolved. Neutral molecules are known to interact with 
clays by physical adsorption (3), and/or by hydrogen bonding (4). Oig~ 
xin ís adsorbed onto montmorílloníte by a reversible adsorptíon mecha-
nísm (5) and degrades by acid-catalyzed hydrolísis. The mechanism of ad 
sorption and degradation of the neutral steroid hydrocortisone by paly-
gorskíte and sepio1ite has be en recently studied (6,7). Two types of fe 
rric iron present in these clays may be responsible for the dífferent 
degradation rates of hydrocortisone. 
Dexamethasone was chosen as the model drug beca use it is one of the 
most powerfu1l antiinflammatory steroid, which is ora11y or topJcally 
administered because of its mínimal mineralcorticoid propertíes. This 
neutral drug degrades by oxidation and may be coadministered wíth clay-
containing pharmaceutica1s. 
Montorillonite was used as a model clay because it possesses the 
highest accesible surface are a and exchange capacity of the clays com-
monly used in pharmacy. 
EXPERIMENTAL 
All chemicals were either offícía1 or reagent grade. An X-ray dif-
fractogram of the clay sample indícated that ít was composed of mont-
moríllonite and traces of quartz. A hígh-pressure Iiquid chrornatogra-
phic method use fuI for the analysis of hydrocortisone and its degra-
dation products (6) was slightly modified for this study. Changes in 
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the A-ring oí dexamethasone were' monitored by UV spectrometry at 240 nm. 
Kinetic studies were carried out at 25, 35 and 55"C. 100 mg oí clay 
was mixed with 30 mI of an aqueous solution 01 dexamethasone (50 pg!ml) 
in 50 mI stoppered centriluge tubes and aged in a shaker-íncubator. At 
appropriate intervals, aliquots were centriluged and supernate was lil 
tered and analyzed by HPLC and UV spectrometry. The pH of each suspen-
si~n was mantained within a range 8.7-9.0. 
The sample preparation for the study of adsorptíon as a lunctíon oí 
concentration was carried out accordíng to the method described lor the 
kinetíc study, but 5-50 pg/ml dexamethasone concentration and 50 mg oÍ 
clay were used. 
RESULTS AND DISCUSSION 
Dexamethasone exhibíted a very slow degradatíon in aqueous solution 
at pH 6-9 and 25"C (Fig. lb). In a montmorll10nite suspension it was ob 
served that dexamethasone content oí the aqueous phase continuously d~ 
creased as determlned by HPLC analysis (Fig. la, D). The degradation pr~ 
lile shown in Fig. la suggests that compounds A (acidic product) and N 
, 
(neutral product) arise directly lrom dex~methasone. However, the degra-
dation prolile (Fig. la) was treated as consisting in three dillerent 
reaction phases (Fig. lb): a) the initial decrease 01 dexamethasone con 
centration lrom 50 to 9 pm/ml, suggested that the drug is adsorbed by 
montmorillonite. This eÍlect was also observed by UV spectrometry and is 
similar but greater than that reported (6) Íor sepiolite~hydrocortisone 
interaction; bl a second reaction phase could be consistent with a ra-
pid degradation rate 01 dexamethasone as shown by HPLC analysis toge-
ther with dexamethasone adsorption'by the clay; el the third reaction 
phase suggests a slow degradation rate oí dexamethasone as indieated by 
HPLC and UV analysis. 
The d(OOl) spacing for montmorillonite in the absenee of drug under 
o 
dehydration conditions was 9.6 A. indicating that no interlayer molec~ 
les (i.e., water or drug) were present in the control sample. Adsorp-
tion oí drug molecules between the layers 01 montmorillonite increased 
o 
the d(OOl) spacing to 14.9 A. This resuIt indicated that dexamethasone 
penetrated into the interIayer space of the cIay and is in agreement 
with the Íirst reaction phase of the degradation proÍile aboye descri-
bed. 
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The IR spectrum of dexamethasone-montmorillonite complex supports 
weak adsorption mechanism. The carbonyl-stretchjng vibration of the C-17 
dexamethasone side-chain shifted from 1705 to 1690 cm-l. In addition, 
the carbonyl-stretching vibration of the C-3 dexamethasone A-ring also 
shifts from 1660 to 1650 cm-l,as aresult of the interaction with montmo 
rillonite. This shift to lower frecuency indicates hydrogen bonding as 
the main adsorption mechanism, although van der Waals' forces also may 
contribute. Desorption studies confirmed that dexamethasone is weakly 
adsorbed by montmorillonite since it was easily desorbed by washing with 
watp,,:",. 
It may be concluded that the montmorillonite-dexamethasone reaction 
mechanism is consistent with a reversible adsorption process and simul-
taneous degradation reaction. 
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